Diet-induced hyperplastic expansion in subcutaneous adipose tissue and protection against adipose progenitor exhaustion in female mice are lost with ovariectomy.

Scheidl, T. B.; Wager, J. L.; Thompson, J.

doi:10.1101/2024.09.05.611480

Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.09.05.611480

Diet-induced hyperplastic expansion in subcutaneous adipose tissue and protection against adipose progenitor exhaustion in female mice are lost with ovariectomy.

Scheidl, T. B.·Wager, J. L.·Thompson, J.

View original source ↗Export metadata ↓

Abstract

BackgroundThe protection of females against cardiometabolic disease is in part attributable to a tendency for fat accumulation in subcutaneous depots, which promote lipid homeostasis by serving as a metabolic sink. At menopause this protection is lost, and body fat distribution resembles the male-like pattern of visceral adiposity. Adipose progenitor cells (APCs) can be recruited to support adipose expansion in the setting of obesity. Sex differences in diet-induced APC responses may in part explain sexual dimorphism in risk for obesity-associated insulin resistance; however, the role of sex and estrogen in governing APC function remains unclear. MethodsFour groups of C57BL/6 mice were assessed: intact males vs. females, and sham vs. ovariectomized (ovx) with or without 17{beta}-estradiol (E2). Adipogenesis was stimulated by rosiglitazone (rosi), while obesity was induced by high fat/fructose diet (HHFD). Flow cytometry quantified the total number of APCs and identify committed preadipocytes by the loss of CD24 expression. Body composition was measured by NMR, while adipose function assessed by measuring circulating adipokines and free fatty acids and lipolysis in adipose explants. ResultsDespite greater accumulation of fat mass in response to rosi, females were protected against the depletion in subcutaneous APCs and preadipocytes that was observed in rosi-treated males. Similar to intact males, APC and preadipocytes in subcutaneous depots of ovx females were reduced after rosi treatment. The protection of obese females against the development of insulin resistance and adipose dysfunction was lost with ovx, and E2 re-supplementation rescued HFFD- induced APC exhaustion. Exposure to HFFD after discontinuation of rosi exacerbated glucose intolerance in males only. ConclusionsEstrogen-mediated hyperplastic expansion in subcutaneous depots permits renewal of the APC pool and preservation of adipose function. PLAIN ENGLISH SUMMARYDespite well-established sex differences in the risk for type 2 diabetes that vary across the lifespan, very little is known regarding sex-specific mechanisms in its pathophysiology. In the setting of obesity, stem cells resident in fat tissue can be recruited for the generation of new fat cells, an important mechanism that maintains metabolic health. It is thought that a reduced availability or dysfunction in fat-residing stem cells is an important pathophysiological event that triggers the onset of obesity-associated type 2 diabetes. Herein, we aimed to determine how sex and estrogen influence stem cell availability and function. Our data show that the ability of fat- residing stem cells to respond to an obesogenic environment is greater in females in an estrogen- dependent manner. Estrogen-dependent stem cell responses to an obesogenic environment may contribute to the protection of females against obesity-induced type 2 diabetes and loss of this protection after menopause. HIGHLIGHTSSexual dimorphism in activation of adipogenesis by rosiglitazone is mediated by estrogen. Exhaustion of the APC pool occurs in subcutaneous depots of male mice, while estrogen mediates protection of females against APC exhaustion. Preservation of subcutaneous adipose expansion capacity due to renewal of the progenitor pool may contribute to protection of females against obesity-associated insulin resistance.

Explore related subjects

physiology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Scheidl, T. B., Wager, J. L., Thompson, J.. 2024-09-06. Diet-induced hyperplastic expansion in subcutaneous adipose tissue and protection against adipose progenitor exhaustion in female mice are lost with ovariectomy.. https://doi.org/10.1101/2024.09.05.611480

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

bioRxiv2026

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

bioRxiv2026

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗